Cellular Pathobiology Section, Cellular Neurobiology Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Baltimore, MD 21224, USA.
Mol Pharmacol. 2010 Apr;77(4):517-28. doi: 10.1124/mol.109.062539. Epub 2010 Jan 6.
Sigma-1 receptors (Sig-1Rs) that bind diverse synthetic and endogenous compounds have been implicated in the pathophysiology of several human diseases such as drug addiction, depression, neurodegenerative disorders, pain-related disorders, and cancer. Sig-1Rs were identified recently as novel ligand-operated molecular chaperones. Although Sig-1Rs are predominantly expressed at endoplasmic reticulum (ER) subdomains apposing mitochondria [i.e., the mitochondria-associated ER membrane (MAM)], they dynamically change the cellular distribution, thus regulating both MAM-specific and plasma membrane proteins. However, what determines the location of Sig-1R at the MAM and how the receptor translocation is initiated is unknown. Here we report that the detergent-resistant membranes (DRMs) play an important role in anchoring Sig-1Rs to the MAM. The MAM, which is highly capable of accumulating ceramides, is enriched with both cholesterol and simple sphingolipids, thus forming Triton X-114-resistant DRMs. Sig-1Rs associate with MAM-derived DRMs but not with those from microsomes. A lipid overlay assay found that solubilized Sig-1Rs preferentially associate with simple sphingolipids such as ceramides. Disrupting DRMs by lowering cholesterol or inhibiting de novo synthesis of ceramides at the ER largely decreases Sig-1R at DRMs and causes translocation of Sig-1R from the MAM to ER cisternae. These findings suggest that the MAM, bearing cholesterol and ceramide-enriched microdomains at the ER, may use the microdomains to anchor Sig-1Rs to the location; thus, it serves to stage Sig-1R at ER-mitochondria junctions.
西格玛-1 受体(Sig-1Rs)能够结合多种合成和内源性化合物,与人类的多种疾病的病理生理学有关,如药物成瘾、抑郁症、神经退行性疾病、与疼痛相关的疾病和癌症。Sig-1Rs 最近被鉴定为新型配体操纵的分子伴侣。尽管 Sig-1Rs 主要表达在内质网(ER)亚区与线粒体相邻的位置(即线粒体相关内质网膜(MAM)),但它们可以动态改变细胞分布,从而调节 MAM 特异性和质膜蛋白。然而,决定 Sig-1R 在 MAM 中的位置以及受体易位如何启动的因素尚不清楚。在这里,我们报告说,去污剂抗性膜(DRMs)在将 Sig-1Rs 锚定到 MAM 中起着重要作用。MAM 高度能够积累神经酰胺,富含胆固醇和简单神经酰胺,从而形成 Triton X-114 抗性 DRMs。Sig-1Rs 与源自 MAM 的 DRMs 相关联,但与源自微粒体的 DRMs 不相关。脂质覆盖测定发现,可溶的 Sig-1Rs 优先与简单神经酰胺(如神经酰胺)相关联。通过降低 ER 中的胆固醇或抑制神经酰胺的从头合成来破坏 DRMs 会大大减少 DRMs 中的 Sig-1R,并导致 Sig-1R 从 MAM 易位到 ER 潴腔。这些发现表明,具有胆固醇和富含神经酰胺的微区的 MAM 可能使用这些微区将 Sig-1Rs 锚定在该位置;因此,它有助于将 Sig-1R 定位于 ER-线粒体连接处。